Latest Ratios: P/E Ratio 50.3x · EV/EBITDA 13.7x · ROE 1.6%. (1998–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $1.2B | $969M | $1.8B | $1.9B | $2.0B | $2.0B | $1.5B | $1.8B | $2.5B | $4.2B | $4.7B |
| Enterprise Value | $2.5B | $2.3B | $3.0B | $3.1B | $3.3B | $2.8B | $2.5B | $2.6B | $3.6B | $5.2B | $5.9B |
| P/E Ratio → | 50.32 | 38.42 | 18.45 | 16.72 | 20.11 | 17.12 | 22.48 | — | 24.33 | 727.70 | 26.60 |
| P/S Ratio | 0.55 | 0.44 | 0.81 | 0.85 | 0.92 | 0.96 | 0.78 | 0.82 | 1.13 | 1.82 | 2.01 |
| P/B Ratio | 0.82 | 0.62 | 1.15 | 1.24 | 1.37 | 1.26 | 1.06 | 1.33 | 1.44 | 2.40 | 2.60 |
| P/FCF | 29.69 | 23.41 | 10.43 | 11.49 | 43.96 | 11.64 | 8.23 | 13.26 | 12.43 | 18.42 | 44.41 |
| P/OCF | 10.38 | 8.19 | 7.88 | 8.86 | 19.65 | 8.75 | 6.54 | 9.22 | 9.52 | 14.13 | 26.91 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 1.03 | 1.33 | 1.40 | 1.51 | 1.36 | 1.26 | 1.24 | 1.59 | 2.27 | 2.48 |
| EV / EBITDA | 13.73 | 12.33 | 10.43 | 9.88 | 12.04 | 8.69 | 9.29 | 7.84 | 9.32 | 11.83 | 13.57 |
| EV / EBIT | 26.35 | 23.61 | 15.19 | 13.91 | 16.76 | 13.22 | 16.57 | — | 15.32 | 320.62 | 20.06 |
| EV / FCF | — | 55.21 | 17.18 | 18.88 | 71.86 | 16.51 | 13.31 | 19.95 | 17.51 | 23.00 | 54.75 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 41.6% | 41.6% | 42.4% | 41.8% | 40.5% | 45.6% | 45.2% | 45.1% | 46.2% | 49.0% | 49.1% |
| Operating Margin | 4.3% | 4.3% | 8.8% | 10.1% | 8.4% | 11.5% | 9.0% | 11.4% | 12.7% | 15.1% | 14.3% |
| Net Profit Margin | 1.1% | 1.1% | 4.4% | 5.1% | 4.6% | 5.6% | 3.5% | -17.4% | 4.6% | 0.2% | 7.6% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 1.6% | 1.6% | 6.3% | 7.6% | 6.5% | 7.8% | 4.9% | -24.3% | 5.9% | 0.3% | 9.7% |
| ROA | 0.7% | 0.7% | 2.6% | 3.1% | 2.7% | 3.3% | 1.9% | -10.1% | 2.5% | 0.1% | 3.7% |
| ROIC | 2.6% | 2.6% | 5.4% | 6.2% | 5.3% | 7.5% | 5.8% | 7.3% | 7.6% | 9.1% | 8.7% |
| ROCE | 3.0% | 3.0% | 6.2% | 7.1% | 5.8% | 7.8% | 6.1% | 8.1% | 8.2% | 9.2% | 8.2% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.99 | 0.99 | 0.87 | 0.94 | 1.00 | 0.83 | 0.91 | 0.93 | 0.74 | 0.89 | 1.01 |
| Debt / EBITDA | 8.32 | 8.32 | 4.82 | 4.55 | 5.37 | 4.03 | 4.92 | 3.64 | 3.40 | 3.50 | 4.28 |
| Net Debt / Equity | — | 0.85 | 0.74 | 0.80 | 0.87 | 0.53 | 0.65 | 0.67 | 0.59 | 0.60 | 0.60 |
| Net Debt / EBITDA | 7.10 | 7.10 | 4.10 | 3.87 | 4.67 | 2.57 | 3.54 | 2.63 | 2.70 | 2.36 | 2.56 |
| Debt / FCF | — | 31.80 | 6.74 | 7.39 | 27.89 | 4.87 | 5.07 | 6.69 | 5.08 | 4.59 | 10.34 |
| Interest Coverage | 1.32 | 1.32 | 2.58 | 2.88 | 2.74 | 3.17 | 2.43 | -5.23 | 3.41 | 0.24 | 4.06 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.76 | 1.76 | 1.66 | 1.84 | 1.75 | 2.12 | 1.93 | 1.58 | 1.33 | 2.26 | 1.67 |
| Quick Ratio | 0.90 | 0.90 | 0.81 | 0.90 | 0.91 | 1.47 | 1.31 | 1.04 | 0.87 | 1.63 | 1.32 |
| Cash Ratio | 0.40 | 0.40 | 0.37 | 0.41 | 0.35 | 0.89 | 0.71 | 0.52 | 0.37 | 0.96 | 0.85 |
| Asset Turnover | — | 0.59 | 0.60 | 0.60 | 0.58 | 0.57 | 0.55 | 0.62 | 0.57 | 0.55 | 0.50 |
| Inventory Turnover | 2.68 | 2.68 | 2.72 | 2.66 | 2.87 | 3.29 | 3.40 | 3.29 | 3.65 | 3.52 | 3.89 |
| Days Sales Outstanding | — | 31.98 | 26.58 | 27.36 | 35.11 | 40.32 | 43.02 | 35.05 | 39.06 | 38.27 | 44.78 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 2.3% | 3.0% | 1.7% | 1.6% | 1.6% | 1.3% | — | — | — | — | — |
| Payout Ratio | 115.4% | 115.4% | 31.1% | 27.5% | 32.8% | 21.7% | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 2.0% | 2.6% | 5.4% | 6.0% | 5.0% | 5.8% | 4.4% | — | 4.1% | 0.1% | 3.8% |
| FCF Yield | 3.4% | 4.3% | 9.6% | 8.7% | 2.3% | 8.6% | 12.1% | 7.5% | 8.0% | 5.4% | 2.3% |
| Buyback Yield | 7.3% | 9.3% | 3.2% | 3.9% | 6.3% | 0.5% | 0.0% | 0.2% | 4.9% | 4.0% | 4.1% |
| Total Shareholder Yield | 9.6% | 12.3% | 4.9% | 5.6% | 7.9% | 1.7% | 0.0% | 0.2% | 4.9% | 4.0% | 4.1% |
| Shares Outstanding | — | $48M | $50M | $52M | $54M | $55M | $55M | $54M | $55M | $58M | $60M |
Margin Compression and Leverage
Based on current market data, Edgewell trades at a forward P/E of 14.62, which appears to reflect a significant 'challenger discount' compared to diversified staples peers like Church & Dwight, suggesting investors remain skeptical of the company's ability to reverse its recent -1.34% revenue contraction trend.
The valuation gap relative to larger peers suggests the market is pricing in a permanent loss of shelf share rather than a cyclical downturn. While the forward multiple is lower than the TTM P/E of 52.30, this compression may be driven by anticipated earnings volatility rather than genuine growth prospects.
As reported in recent financial statements, ROIC has trended toward zero, reaching 0.5% in 2026Q2, which indicates that the company is failing to generate returns above its cost of capital and is struggling to compound value through its current portfolio of personal care assets.
The consistent decay in ROIC from 2.3% in 2024Q3 highlights that capital allocation toward brand acquisitions has not yet yielded the expected margin expansion. Investors should monitor whether this trend reflects structural over-investment in stagnant categories or an inability to optimize the cost base of acquired brands.
According to quarterly filings, the cash conversion cycle has expanded to 99 days in 2026Q2, driven by persistent inventory bloat that significantly lags industry standards and suggests that the company is struggling to align its manufacturing output with actual consumer demand in the wet shave segment.
The elevated DIO of 136 days indicates that capital is being trapped in unsold inventory, which directly pressures free cash flow. This inefficiency appears to be a structural drag on the balance sheet, limiting the company's ability to pivot resources toward higher-growth skin care initiatives.
Based on reported figures, the company's debt-to-equity ratio of 0.88 in 2026Q2, combined with erratic interest coverage, suggests that the firm's financial flexibility is increasingly constrained, leaving little room for error as it navigates a period of negative net margins and persistent revenue stagnation.
The volatility in interest coverage, which dipped into negative territory in 2026Q1, warrants close investigation by investors concerned with refinancing risk. The current leverage profile appears vulnerable to any further deterioration in operating cash flow, potentially forcing management to prioritize debt reduction over strategic brand investment.
The P/E ratio is frequently misapplied to Edgewell, as it obscures the impact of one-time restructuring charges and seasonal inventory write-downs that distort net income, making EV/EBITDA a more reliable metric for assessing the company's true operational earning power and underlying cash generation capabilities.
Because the company is in a phase of active portfolio transformation, net income is often a poor proxy for performance. Analysts should instead focus on EV/EBITDA to normalize for the capital structure and the non-recurring costs associated with the company's ongoing efficiency initiatives.
Includes 30+ ratios · 28 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying EPC stock.
Edgewell Personal Care Company's current P/E ratio is 50.3x. The historical average is 15.8x. This places it at the 100th percentile of its historical range.
Edgewell Personal Care Company's current EV/EBITDA is 13.7x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 9.6x.
Edgewell Personal Care Company's return on equity (ROE) is 1.6%. The historical average is 17.3%.
Based on historical data, Edgewell Personal Care Company is trading at a P/E of 50.3x. This is at the 100th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Edgewell Personal Care Company's current dividend yield is 2.31% with a payout ratio of 115.4%.
Edgewell Personal Care Company has 41.6% gross margin and 4.3% operating margin.
Edgewell Personal Care Company's Debt/EBITDA ratio is 8.3x, indicating high leverage. A ratio above 4x may signal elevated financial risk.